Cargando…
Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427306/ https://www.ncbi.nlm.nih.gov/pubmed/32639662 http://dx.doi.org/10.1002/cac2.12070 |
_version_ | 1783570852821860352 |
---|---|
author | Lin, Zhihuan Zhang, Yaxiong Zhang, Li |
author_facet | Lin, Zhihuan Zhang, Yaxiong Zhang, Li |
author_sort | Lin, Zhihuan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7427306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74273062020-08-16 Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer Lin, Zhihuan Zhang, Yaxiong Zhang, Li Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2020-07-08 /pmc/articles/PMC7427306/ /pubmed/32639662 http://dx.doi.org/10.1002/cac2.12070 Text en © 2020 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Letters to the Editor Lin, Zhihuan Zhang, Yaxiong Zhang, Li Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer |
title | Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer |
title_full | Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer |
title_fullStr | Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer |
title_full_unstemmed | Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer |
title_short | Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer |
title_sort | construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427306/ https://www.ncbi.nlm.nih.gov/pubmed/32639662 http://dx.doi.org/10.1002/cac2.12070 |
work_keys_str_mv | AT linzhihuan constructionofanintegratedprognosticclassifiermodelforpredictingtheefficacyofimmunecheckpointinhibitortherapyinnonsmallcelllungcancer AT zhangyaxiong constructionofanintegratedprognosticclassifiermodelforpredictingtheefficacyofimmunecheckpointinhibitortherapyinnonsmallcelllungcancer AT zhangli constructionofanintegratedprognosticclassifiermodelforpredictingtheefficacyofimmunecheckpointinhibitortherapyinnonsmallcelllungcancer |